Classification of variants of uncertain significance in BRCA1 and BRCA2 using personal and family history of cancer from individuals in a large hereditary cancer multigene panel testing cohort
Open Access
- 1 April 2020
- journal article
- research article
- Published by Elsevier BV in Genetics in Medicine
- Vol. 22 (4), 701-708
- https://doi.org/10.1038/s41436-019-0729-1
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- A clinical guide to hereditary cancer panel testing: evaluation of gene-specific cancer associations and sensitivity of genetic testing criteria in a cohort of 165,000 high-risk patientsGenetics in Medicine, 2019
- Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classificationHuman Mutation, 2019
- A quantitative model to predict pathogenicity of missense variants in the TP53 geneHuman Mutation, 2019
- BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2PLoS Genetics, 2018
- Quality of Clinician-Reported Cancer History When Ordering Genetic TestingJCO Clinical Cancer Informatics, 2018
- Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction modelsGenetics in Medicine, 2018
- Preferences for multigene panel testing for hereditary breast cancer risk among ethnically diverse BRCA-uninformative familiesJournal of Community Genetics, 2018
- Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populationsCancer Genetics, 2016
- Development and validation of a new algorithm for the reclassification of genetic variants identified in the BRCA1 and BRCA2 genesBreast Cancer Research and Treatment, 2014
- A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS)Human Mutation, 2011